Aynur Hermann

2.2k total citations
6 papers, 160 citations indexed

About

Aynur Hermann is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, Aynur Hermann has authored 6 papers receiving a total of 160 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Radiology, Nuclear Medicine and Imaging and 2 papers in Molecular Biology. Recurrent topics in Aynur Hermann's work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Aynur Hermann is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Peptidase Inhibition and Analysis (2 papers). Aynur Hermann collaborates with scholars based in United States and Germany. Aynur Hermann's co-authors include Bruce R. Conklin, James Onuffer, Krista A. McNally, Jason S. Park, Carmen Zhou, Wendell A. Lim, Orion D. Weiner, Delquin Gong, William C. Olson and Erica Ullman and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Molecular Cancer Therapeutics.

In The Last Decade

Aynur Hermann

6 papers receiving 158 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Aynur Hermann United States	4	86	71	42	31	16	6	160
Dalia K. Omran United States	7	112 1.3×	48 0.7×	62 1.5×	11 0.4×	8 0.5×	8	158
Diana Alvarez Arias United States	5	150 1.7×	120 1.7×	141 3.4×	25 0.8×	16 1.0×	10	278
Tarek Taifour Canada	4	98 1.1×	97 1.4×	93 2.2×	23 0.7×	6 0.4×	8	224
Adam Karoutas United Kingdom	5	48 0.6×	167 2.4×	47 1.1×	17 0.5×	12 0.8×	6	250
Céline Merlin Belgium	7	34 0.4×	94 1.3×	35 0.8×	20 0.6×	24 1.5×	10	181
Lena Boehme United Kingdom	7	56 0.7×	128 1.8×	53 1.3×	14 0.5×	6 0.4×	9	227
Elena C. Sigmund Switzerland	6	97 1.1×	45 0.6×	61 1.5×	10 0.3×	10 0.6×	8	156
Yahaya A Yabo Norway	5	40 0.5×	84 1.2×	40 1.0×	24 0.8×	9 0.6×	11	191
Maria C. Heinz Netherlands	4	94 1.1×	93 1.3×	27 0.6×	22 0.7×	6 0.4×	5	211
Alison K. Esser United States	8	69 0.8×	93 1.3×	49 1.2×	22 0.7×	7 0.4×	11	182

Countries citing papers authored by Aynur Hermann

Since Specialization

Citations

This map shows the geographic impact of Aynur Hermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aynur Hermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aynur Hermann more than expected).

Fields of papers citing papers by Aynur Hermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aynur Hermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aynur Hermann. The network helps show where Aynur Hermann may publish in the future.

Co-authorship network of co-authors of Aynur Hermann

This figure shows the co-authorship network connecting the top 25 collaborators of Aynur Hermann. A scholar is included among the top collaborators of Aynur Hermann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aynur Hermann. Aynur Hermann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Olson, Kara, David J. DiLillo, Olga Sineshchekova, et al.. (2024). A CD38xCD28 Costimulatory Bispecific Antibody Demonstrates Potent Preclinical Combinatorial Activity with a BCMAxCD3 T Cell-Engager. Blood. 144(Supplement 1). 3283–3283. 1 indexed citations

2.

Lee, Ken-Wing, Yi Zhou, Matthew C. Franklin, et al.. (2024). Characterization of Linvoseltamab's BCMA Binding Epitope and Efficacy Against BCMA Mutations in Relapsed/Refractory Multiple Myeloma. Blood. 144(Supplement 1). 3265–3265. 7 indexed citations

3.

Bloch, Nicolin, Jurriaan Brouwer‐Visser, Erica Ullman, et al.. (2022). Interference in a Neutralizing Antibody Assay for Odronextamab, a CD20xCD3 Bispecific mAb, from Prior Rituximab Therapy and Possible Mitigation Strategy. The AAPS Journal. 24(4). 76–76. 2 indexed citations

4.

Burova, Elena, Aynur Hermann, Jie Dai, et al.. (2019). Preclinical Development of the Anti-LAG-3 Antibody REGN3767: Characterization and Activity in Combination with the Anti-PD-1 Antibody Cemiplimab in Human PD-1xLAG-3 –Knockin Mice. Molecular Cancer Therapeutics. 18(11). 2051–2062. 62 indexed citations

5.

Park, Jason S., Aynur Hermann, Krista A. McNally, et al.. (2014). Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal. Proceedings of the National Academy of Sciences. 111(16). 5896–5901. 85 indexed citations

6.

Veit, Michael, et al.. (2008). Characterization of equine arteritis virus particles and demonstration of their hemolytic activity. Archives of Virology. 153(2). 351–356. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact